EP 3031441 A4 20170208 - CURABLE CALCIUM PHOSPHATE COMPOSITION FOR IN VIVO HARD TISSUE REPAIR, BONE REPAIR MATERIAL, AND VARIOUS DENTAL MATERIALS
Title (en)
CURABLE CALCIUM PHOSPHATE COMPOSITION FOR IN VIVO HARD TISSUE REPAIR, BONE REPAIR MATERIAL, AND VARIOUS DENTAL MATERIALS
Title (de)
HÄRTBARE CALCIUMPHOSPHATZUSAMMENSETZUNG FÜR IN-VIVO-HARTGEWEBEREPARATUR, KNOCHENREPARATURMATERIAL UND VERSCHIEDENE DENTALMATERIALIEN
Title (fr)
COMPOSITION DE PHOSPHATE DE CALCIUM DURCISSABLE POUR RÉPARATION DE TISSU DUR BIOLOGIQUE, MATÉRIAU DE RÉPARATION DES OS, ET MATÉRIAUX DENTAIRES DIVERS
Publication
Application
Priority
- JP 2013163389 A 20130806
- JP 2014004076 W 20140804
Abstract (en)
[origin: EP3031441A1] The present invention provides a curable calcium phosphate composition for biological hard tissue repair that yields a cured product excellent in durability in a wet environment such as in a body or an oral cavity. The present invention relates to a curable calcium phosphate composition for biological hard tissue repair, including tetracalcium phosphate particles (A), calcium hydrogen phosphate particles (B), calcium carbonate particles (C), and water (D), the curable calcium phosphate composition including 5 to 75 parts by weight of the tetracalcium phosphate particles (A), 10 to 70 parts by weight of the calcium hydrogen phosphate particles (B), and 2 to 50 parts by weight of the calcium carbonate particles (C) per 100 parts by weight of the total of the tetracalcium phosphate particles (A), the calcium hydrogen phosphate particles (B), and the calcium carbonate particles (C).
IPC 8 full level
A61K 6/00 (2006.01); A61K 6/027 (2006.01); A61K 6/033 (2006.01); A61K 6/04 (2006.01); A61K 6/838 (2020.01); A61K 8/02 (2006.01); A61K 8/19 (2006.01); A61K 8/21 (2006.01); A61K 8/24 (2006.01); A61L 27/12 (2006.01); A61Q 11/00 (2006.01)
CPC (source: EP US)
A61K 6/00 (2013.01 - EP US); A61K 6/20 (2020.01 - EP US); A61K 6/54 (2020.01 - EP US); A61K 6/75 (2020.01 - EP US); A61K 6/838 (2020.01 - EP US); A61K 6/864 (2020.01 - EP US); A61K 33/10 (2013.01 - EP US); A61K 33/42 (2013.01 - EP US); A61L 27/12 (2013.01 - EP US); A61L 2430/02 (2013.01 - EP US); A61L 2430/12 (2013.01 - EP US); A61M 2025/0019 (2013.01 - US)
Citation (search report)
- [Y] US 2012027829 A1 20120202 - HASHIMOTO TADASHI [JP], et al & WO 2010113800 A1 20101007 - KURARAY MEDICAL INC [JP], et al
- [Y] US 2013189337 A1 20130725 - HASHIMOTO TADASHI [JP], et al & WO 2012046667 A1 20120412 - KURARAY MEDICAL INC [JP], et al
- [Y] WO 0078270 A1 20001228 - UNIV NEW YORK STATE RES FOUND [US], et al
- [Y] US 2010236449 A1 20100923 - HASHIMOTO TADASHI [JP], et al
- [Y] FR 2830249 A1 20030404 - TOULOUSE INST NAT POLYTECH [FR]
- [AD] DATABASE WPI Week 200759, Derwent World Patents Index; AN 2007-617605, XP002765516
- See references of WO 2015019600A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
DOCDB simple family (publication)
EP 3031441 A1 20160615; EP 3031441 A4 20170208; EP 3031441 B1 20210203; JP 6316296 B2 20180425; JP WO2015019600 A1 20170302; US 2016175355 A1 20160623; US 9827268 B2 20171128; WO 2015019600 A1 20150212
DOCDB simple family (application)
EP 14834444 A 20140804; JP 2014004076 W 20140804; JP 2015530701 A 20140804; US 201414910140 A 20140804